Goldman, J. W., Raju, R. N., Gordon, G. A., El-Hariry, I., Teofilivici, F., Vukovic, V. M., . . . Rosen, L. S. (2013). A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies. BioMed Central.
Chicago ZitierstilGoldman, Jonathan W., et al. A First in Human, Safety, Pharmacokinetics, and Clinical Activity Phase I Study of Once Weekly Administration of the Hsp90 Inhibitor Ganetespib (STA-9090) in Patients With Solid Malignancies. BioMed Central, 2013.
MLA ZitierstilGoldman, Jonathan W., et al. A First in Human, Safety, Pharmacokinetics, and Clinical Activity Phase I Study of Once Weekly Administration of the Hsp90 Inhibitor Ganetespib (STA-9090) in Patients With Solid Malignancies. BioMed Central, 2013.